Monday, May 30, 2016

 

 



Soy un nuevo usuario

Olvidé mi contraseña

Entrada usuarios

Lógica Matemáticas Astronomía y Astrofísica Física Química Ciencias de la Vida
Ciencias de la Tierra y Espacio Ciencias Agrarias Ciencias Médicas Ciencias Tecnológicas Antropología Demografía
Ciencias Económicas Geografía Historia Ciencias Jurídicas y Derecho Lingüística Pedagogía
Ciencia Política Psicología Artes y Letras Sociología Ética Filosofía


A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells12

1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario
    registrado en Universia


  Descargar recurso

Detalles del recurso

Pertenece a: PubMed Central (PMC3 - NLM DTD)  

Descripción: The tumor suppressor p53 is often inactivated in breast cancer cells because the overexpression of its repressors (e.g., MDM2 and MDMX). Restoration of p53 activity by small molecules through counteracting p53 repressors can lead to in vivo tumor regression and is therefore considered a promising strategy for treatments of cancer. Recent efforts in high-throughput drug screening and rational drug design have identified several structurally diverse small-molecule p53 activators, including a pseudourea derivative XI-011 (NSC146109). This small molecule strongly activates p53 while selectively inhibiting growth of transformed cells without inducing genotoxicity, indicating its potential as a drug lead for p53-targeted therapy. However, the mechanism(s) by which XI-011 activates p53 and the effects of XI-011 on growth of breast cancer cells are currently unknown. Here, we report that XI-011 promoted breast cancer cells to undergo apoptosis through activating p53 and inducing expression of proapoptotic genes. Importantly, we found that activation of p53 by this small molecule was achieved through a novel mechanism, that is, inhibition of MDMX expression. XI-011 repressed the MDMX promoter, resulting in down-regulation of MDMX messenger RNA level in MCF-7 cells. In line with these results, XI-011 decreased the viability of breast cancer cells expressing low levels of MDMX in a less-efficient manner. Interestingly, XI-011 acted additively with the MDM2 antagonist Nutlin-3a to inhibit growth of breast cancer cells. We conclude that XI-011 belongs to a novel class of small-molecule p53 activators that target MDMX and could be of value in treating breast cancer.

Autor(es): Wang, Hongbo -  Yan, Chunhong - 

Id.: 54060131

Idioma: English  - 

Versión: 1.0

Estado: Final

Palabras claveResearch Article - 

Tipo de recurso: Text  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 01-ago-2011

Contacto:

Localización:


Otros recursos del mismo autor(es)

  1. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression RNF126 is an E3 ubiquitin ligase. The deletion of RNF126 gene was observed in a wide range of human ...
  2. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction Aerobic glycolysis regulates T cell function. However, if and how primary cancer alters T cell glyco...
  3. The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation
  4. Loss of ATF3 Promotes Akt Activation and Prostate Cancer Development in a Pten Knockout Mouse Model Activating transcription factor 3 (ATF3) responds to diverse cellular stresses, and regulates oncoge...
  5. Article A Comparison of Postoperative Early Enteral Nutrition with Delayed Enteral Nutrition in Patients with Esophageal Cancer www.mdpi.com/journal/nutrients

Otros recursos de la misma colección

  1. Oncostatin-M Differentially Regulates Mesenchymal and Proneural Signature Genes in Gliomas via STAT3 Signaling1 Glioblastoma (GBM), the most malignant of the brain tumors is classified on the basis of molecular s...
  2. Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC Anti-angiogenic treatment with tyrosine kinase inhibitors (TKI) has lead to an impressive increase i...
  3. Molecular Subtypes of Uterine Leiomyosarcoma and Correlation with Clinical Outcome12 The molecular etiology of uterine leiomyosarcoma (ULMS) is poorly understood, which accounts for the...
  4. Detection of Non-Melanoma Skin Cancer by in vivo Fluorescence Imaging with Fluorocoxib A Non-melanoma skin cancer (NMSC) is the most common form of cancer in the US and its incidence is inc...
  5. Constitutively Active Akt1 Cooperates with KRasG12D to Accelerate In Vivo Pancreatic Tumor Onset and Progression☆☆☆ BACKGROUND AND AIMS: Pancreatic adenocarcinoma is a deadly disease characterized by metastatic progr...

Valoración de los usuarios

No hay ninguna valoración para este recurso.Sea el primero en valorar este recurso.
 

Busque un recurso